Lonza Group Continues To Leverage Biopharma's Optimization Push

More and more it feels like companies across industries have bought into the idea that it is often best to specialize in whatever it is they do best and outsource as much of what remains as is practical. In the caseAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other tha ...